Santiago Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 9 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 16-12-2024
- Revenue 94.57%
(FY 2022)
- Profit 114.09%
(FY 2022)
- Ebitda -109.17%
(FY 2022)
- Net Worth 65.83%
(FY 2022)
- Total Assets 59.80%
(FY 2022)
About Santiago Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Durga Budhrani, Ankur Budhrani, and Shubham Budhrani serve as directors at the Company.
- CIN/LLPIN
U24100MP2016PTC035265
- Company No.
035265
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Santiago Life Sciences Private Limited offer?
Santiago Life Sciences Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anesthetic, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Antiviral Drugs, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at Santiago Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Durga Budhrani  | Director | 22-Jan-2016 | Current |
| Ankur Budhrani | Director | 22-Jan-2016 | Current |
| Shubham Budhrani | Director | 22-Jan-2016 | Current |
Financial Performance of Santiago Life Sciences.
Santiago Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 94.57% increase. The company also saw a substantial improvement in profitability, with a 114.09% increase in profit. The company's net worth Soared by an impressive increase of 65.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Santiago Life Sciences?
In 2020, Santiago Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arico Healthcare LlpActive 5 years 7 monthsDurga Budhrani, Ankur Budhrani and 1 more are mutual person
- Kabeer Logistics And Promoters Private LimitedActive 15 years 3 months
Ankur Budhrani is a mutual person
- The Grand Laavanya Resort & Hotel Private LimitedActive 11 years 11 months
Ankur Budhrani and Shubham Budhrani are mutual person
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2022 | Hdfc Bank Limited | ₹4.50 M | Open |
How Many Employees Work at Santiago Life Sciences?
Unlock and access historical data on people associated with Santiago Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Santiago Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santiago Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.